Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H28O2 |
| Molecular Weight | 312.4458 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@]12CC
InChI
InChIKey=OXHNQTSIKGHVBH-ANULTFPQSA-N
InChI=1S/C21H28O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h9,11,13,18-19,23H,3-8,10,12H2,1-2H3/t18-,19+,20+,21+/m1/s1
| Molecular Formula | C21H28O2 |
| Molecular Weight | 312.4458 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| The androgenic anabolic steroid tetrahydrogestrinone produces dioxin-like effects via the aryl hydrocarbon receptor. | 2012-10 |
|
| A concentration addition model for the activation of the constitutive androstane receptor by xenobiotic mixtures. | 2009-01 |
|
| Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods. | 2006-11 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:46:09 GMT 2025
by
admin
on
Mon Mar 31 21:46:09 GMT 2025
|
| Record UNII |
643MR6L9LB
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-Tetrahydrogestrinone
Created by
admin on Mon Mar 31 21:46:09 GMT 2025 , Edited by admin on Mon Mar 31 21:46:09 GMT 2025
|
||
|
DEA NO. |
4000
Created by
admin on Mon Mar 31 21:46:09 GMT 2025 , Edited by admin on Mon Mar 31 21:46:09 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
643MR6L9LB
Created by
admin on Mon Mar 31 21:46:09 GMT 2025 , Edited by admin on Mon Mar 31 21:46:09 GMT 2025
|
PRIMARY | |||
|
m10629
Created by
admin on Mon Mar 31 21:46:09 GMT 2025 , Edited by admin on Mon Mar 31 21:46:09 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID60210901
Created by
admin on Mon Mar 31 21:46:09 GMT 2025 , Edited by admin on Mon Mar 31 21:46:09 GMT 2025
|
PRIMARY | |||
|
618903-56-3
Created by
admin on Mon Mar 31 21:46:09 GMT 2025 , Edited by admin on Mon Mar 31 21:46:09 GMT 2025
|
PRIMARY | |||
|
6857686
Created by
admin on Mon Mar 31 21:46:09 GMT 2025 , Edited by admin on Mon Mar 31 21:46:09 GMT 2025
|
PRIMARY | |||
|
DB06870
Created by
admin on Mon Mar 31 21:46:09 GMT 2025 , Edited by admin on Mon Mar 31 21:46:09 GMT 2025
|
PRIMARY | |||
|
Tetrahydrogestrinone
Created by
admin on Mon Mar 31 21:46:09 GMT 2025 , Edited by admin on Mon Mar 31 21:46:09 GMT 2025
|
PRIMARY | |||
|
300000036282
Created by
admin on Mon Mar 31 21:46:09 GMT 2025 , Edited by admin on Mon Mar 31 21:46:09 GMT 2025
|
PRIMARY |